control siv rebound structured treatment interruptions early infection 
randomized controlled trial acute simian immunodeficiency virus siv-infected macaques highly active antiretroviral therapy haart haart fixed-schedule structured treatment interruption sti-haart alternating weeks weeks therapy suppressed viral load sti-haart group t cell virus-specific immune response vir control viral rebound increased concurrently subsequent interruptions contrast vir increase siv rebounded permanent treatment withdrawal animals continuous haart fixed-schedule sti-haart appears effective alternative continuous haart early treatment retroviral infection 
